Global Animal Antibacterial Peptide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal Antibacterial Peptide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.
Animal Antibacterial Peptide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Antibacterial Peptide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Poultry and Livestock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Antibacterial Peptide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Antibacterial Peptide key manufacturers include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc. Merial, Zoetis, Bayer HealthCare are top 3 players and held % sales share in total in 2022.
Animal Antibacterial Peptide can be divided into Anionic Peptides and Cationic Peptide, etc. Anionic Peptides is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal Antibacterial Peptide is widely used in various fields, such as Poultry and Livestock, etc. Poultry provides greatest supports to the Animal Antibacterial Peptide industry development. In 2022, global % sales of Animal Antibacterial Peptide went into Poultry filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Antibacterial Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Segment by Type
Anionic Peptides
Cationic Peptide
Poultry
Livestock
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Animal Antibacterial Peptide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal Antibacterial Peptide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal Antibacterial Peptide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Animal Antibacterial Peptide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal Antibacterial Peptide introduction, etc. Animal Antibacterial Peptide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Animal Antibacterial Peptide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Animal Antibacterial Peptide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Antibacterial Peptide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Poultry and Livestock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Antibacterial Peptide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Antibacterial Peptide key manufacturers include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc. Merial, Zoetis, Bayer HealthCare are top 3 players and held % sales share in total in 2022.
Animal Antibacterial Peptide can be divided into Anionic Peptides and Cationic Peptide, etc. Anionic Peptides is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal Antibacterial Peptide is widely used in various fields, such as Poultry and Livestock, etc. Poultry provides greatest supports to the Animal Antibacterial Peptide industry development. In 2022, global % sales of Animal Antibacterial Peptide went into Poultry filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Antibacterial Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Segment by Type
Anionic Peptides
Cationic Peptide
Segment by Application
Poultry
Livestock
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Animal Antibacterial Peptide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal Antibacterial Peptide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal Antibacterial Peptide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Animal Antibacterial Peptide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal Antibacterial Peptide introduction, etc. Animal Antibacterial Peptide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Animal Antibacterial Peptide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
